oleic acid and arachidonyl-2-chloroethylamide

oleic acid has been researched along with arachidonyl-2-chloroethylamide in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Breitenbucher, JG; Seierstad, M	1
De Gottardi, A; Hadengue, A; Ravier-Dall'Antonia, F; Spahr, L	1

Reviews

1 review(s) available for oleic acid and arachidonyl-2-chloroethylamide

Article	Year
Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors. Journal of medicinal chemistry, 2008, Dec-11, Volume: 51, Issue:23 Topics: Amidohydrolases; Animals; Drug Discovery; Enzyme Inhibitors; Humans; Molecular Structure; Structure-Activity Relationship	2008

Other Studies

1 other study(ies) available for oleic acid and arachidonyl-2-chloroethylamide

Article	Year
Cannabinoid receptor 1 and 2 agonists increase lipid accumulation in hepatocytes. Liver international : official journal of the International Association for the Study of the Liver, 2010, Volume: 30, Issue:10 Topics: Apolipoproteins B; Arachidonic Acids; Biological Transport; Blotting, Western; Cannabinoids; Carnitine O-Palmitoyltransferase; Dose-Response Relationship, Drug; Fatty Acid Synthase, Type I; Fatty Liver; Gene Expression Regulation; Hep G2 Cells; Hepatocytes; Humans; Lipid Metabolism; Non-alcoholic Fatty Liver Disease; Oleic Acid; Phosphatidylcholine-Sterol O-Acyltransferase; Receptor Cross-Talk; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Reverse Transcriptase Polymerase Chain Reaction; Sterol Regulatory Element Binding Protein 1; Triglycerides; Up-Regulation	2010

Article

Year

Cannabinoid receptor 1 and 2 agonists increase lipid accumulation in hepatocytes.

Liver international : official journal of the International Association for the Study of the Liver, 2010, Volume: 30, Issue:10

Topics: Apolipoproteins B; Arachidonic Acids; Biological Transport; Blotting, Western; Cannabinoids; Carnitine O-Palmitoyltransferase; Dose-Response Relationship, Drug; Fatty Acid Synthase, Type I; Fatty Liver; Gene Expression Regulation; Hep G2 Cells; Hepatocytes; Humans; Lipid Metabolism; Non-alcoholic Fatty Liver Disease; Oleic Acid; Phosphatidylcholine-Sterol O-Acyltransferase; Receptor Cross-Talk; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Reverse Transcriptase Polymerase Chain Reaction; Sterol Regulatory Element Binding Protein 1; Triglycerides; Up-Regulation

2010